Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression

por Omori, Toshinori, Tazawa, Hiroshi, Yamakawa, Yasuaki, Osaki, Shuhei, Hasei, Joe, Sugiu, Kazuhisa, Komatsubara, Tadashi, Fujiwara, Tomohiro, Yoshida, Aki, Kunisada, Toshiyuki, Urata, Yasuo, Kagawa, Shunsuke, Ozaki, Toshifumi, Fujiwara, Toshiyoshi
Publicado 2021

Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas

por Osaki, Shuhei, Tazawa, Hiroshi, Hasei, Joe, Yamakawa, Yasuaki, Omori, Toshinori, Sugiu, Kazuhisa, Komatsubara, Tadashi, Fujiwara, Tomohiro, Sasaki, Tsuyoshi, Kunisada, Toshiyuki, Yoshida, Aki, Urata, Yasuo, Kagawa, Shunsuke, Ozaki, Toshifumi, Fujiwara, Toshiyoshi
Publicado 2016

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction

por Yamakawa, Yasuaki, Tazawa, Hiroshi, Hasei, Joe, Osaki, Shuhei, Omori, Toshinori, Sugiu, Kazuhisa, Komatsubara, Tadashi, Uotani, Kouji, Fujiwara, Tomohiro, Yoshida, Aki, Kunisada, Toshiyuki, Urata, Yasuo, Kagawa, Shunsuke, Ozaki, Toshifumi, Fujiwara, Toshiyoshi
Publicado 2017

Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma

por Fujiwara, Tomohiro, Uotani, Koji, Yoshida, Aki, Morita, Takuya, Nezu, Yutaka, Kobayashi, Eisuke, Yoshida, Akihiko, Uehara, Takenori, Omori, Toshinori, Sugiu, Kazuhisa, Komatsubara, Tadashi, Takeda, Ken, Kunisada, Toshiyuki, Kawamura, Machiko, Kawai, Akira, Ochiya, Takahiro, Ozaki, Toshifumi
Publicado 2017